Concepedia

Anne Vaigro-Wolff

AV

4

Publications

3.4K

Citations

4

H-Index

1991

Active since

Affiliations

National Cancer Institute(Current)

Anne Vaigro-Wolff is an author at National Cancer Institute specializing in medicine, cancer biology, and chemical biology.

Top concepts

Publications per year

1991–2000

4

Publications

4

Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

Anne Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute · 1991 · 3.2K citations

UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in Human Tumor Cell Lines

Anne Monks, Erik Harris, Anne Vaigro-Wolff et al. · Investigational New Drugs · 2000 · 74 citations

, , +11

Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the COMPARE program

Emily S. Cleaveland, Anne Monks, Anne Vaigro-Wolff et al. · Biochemical Pharmacology · 1995 · 40 citations

, , +11

The ras Oncogene-Mediated Sensitization of Human Cells to Topoisomerase II Inhibitor-Induced Apoptosis

Han Koo, M. Gray-Goodrich, Glenda Kohlhagen et al. · JNCI Journal of the National Cancer Institute · 1999 · 33 citations · Full text

Rows per page

1–4 of 4